Clinical Trials Logo

Pseudophakia clinical trials

View clinical trials related to Pseudophakia.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06460389 Recruiting - Cataract Clinical Trials

Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation With and Without Digital Assistance

Start date: January 1, 2024
Phase:
Study type: Observational

The primary objective of this study is to compare the postoperative visual acuity curves of patients that underwent one of the following surgical procedures: Insertion of an extended depth of focus intraocular lens with digital assistance and insertion of an extended depth of focus intraocular lens without digital assistance.

NCT ID: NCT06260852 Recruiting - Cataract Clinical Trials

Identification of Minimum Focal Points in Vision Curve Formation

Start date: February 1, 2024
Phase:
Study type: Observational

The primary objective of this study is to identify how many focal points and at which distances are necessary for reliable visual curve formation and area of the curve (AoC) calculation using mathematical models and comparing the results to measurements acquired from participants that underwent uncomplicated pseudophakic presbyopia surgery.

NCT ID: NCT06065072 Recruiting - Cataract Clinical Trials

Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900

Start date: June 23, 2023
Phase:
Study type: Observational

This is a prospective comparative study that will be conducted at one clinical site in the United States, in which subjects who sign an informed consent form and fulfil all inclusion and exclusion criteria, will have OCT scans obtained using the test and the predicate devices. There will be two main types of analyses performed as part of this study, including 1) a precision analysis, and 2) an agreement analysis. The precision analyses will be conducted utilizing all complete complements of acceptable scans from the test devices and predicate device for each of the 3 configurations. A complete complement of acceptable scans can be defined as subjects having 3 acceptable replicate scans on each of the 3 devices, at each of the 3 configurations. This is also synonymous with 3 scans for each of the 3 configurations on all 3 devices. If subjects have more than 3 acceptable scans per configuration on a device, only the first 3 will be considered for analyses. The agreement analysis will be conducted utilizing the first set of acceptable scans from each instrument for all overlapping measurement types (for all measurement types two or more of the devices have in common) related to performance endpoints.

NCT ID: NCT06064916 Recruiting - Pseudophakia Clinical Trials

Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients

Start date: July 25, 2023
Phase:
Study type: Observational [Patient Registry]

This is a non-interventional, prospective, observational study of the outcomes for post myopic refractive surgery patients following successful, uncomplicated cataract surgery with bilateral implantation of the Vivity IOL (DAT***/CCWET*). Patients will be assessed for monocular and binocular distance, intermediate, and near vision.

NCT ID: NCT06041139 Recruiting - Pseudophakia Clinical Trials

Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

Start date: September 12, 2022
Phase:
Study type: Observational

Background: - The Tecnis Synergy intraocular lens (IOL) has a claim to allow patients to experience continuous high-contrast vision from far through near even in low-light conditions. - A J&J-sponsored post marketing study done outside of the US claim superiority of range of vision for the Tecnis Synergy IOL over the PanOptix IOL. Hypothesis: - Patients with bilateral Panoptix IOLs have non-inferior distance, intermediate, and near visual acuity compared to patients with bilateral Synergy IOLs in both photopic and mesopic conditions with less glare, haloes, and/or starbursts. Unmet Medical Need: - There is a need to look at patient visual outcomes and the visual disturbance profile comparing trifocal technology with combined EDOF/Bifocal technology in the United States.

NCT ID: NCT04175951 Recruiting - Cataract Senile Clinical Trials

Tecnis Eyhance Versus Rayner RayOne Study

Start date: October 24, 2019
Phase: N/A
Study type: Interventional

Cataract surgery involves replacing milky lens with a plastic intraocular lens. This plastic lens can be either monofocal (fixates for distance or near without glasses), extended depth of focus (EDOF)(fixates for intermediate and distance vision only without glasses) or multifocal lenses (fixates for distance, intermediate and near vision without glasses). However, EDOF and multifocal lenses are known to produce glare and halos. Tecnis Eyhance (Johnson & Johnson, USA) is a monofocal IOL which give added intermediate vision without employing EDOF or multifocal technology and hence induces no glare and halos. Whereas monofocal IOLs such as RayOne do not give intermediate vision. The objective is to assess visual and optical performance of Tecnis Eyhance versus Rayner RayOne in a prospective, randomized, comparative bilateral study. The proposed study will be the first study comparing the new technology monofocal Eyhance with conventional RayOne Rayner lens to assess the added benefits of Eyhance technology at multiple visits until 3 months after the surgery. Patients attending the clinics with cataracts will be invited to participate in this randomised study. They will be randomised to receive either Eyhance or RayOne in both eyes through surgeries performed not more than 2 weeks apart. The patients will be followed up at 1 and 3 months in the research clinic to assess the uniocular and binocular vision, spectacle prescription, a simple non-invasive scan to look at any distortions in the optics of the eye (wavefront aberrometry) and questionnaire for assessing subjective outcomes, glare and halos.

NCT ID: NCT03825081 Recruiting - Presbyopia Clinical Trials

Pilocarpine and Brimonidine in Patients With Monofocal Lenses

Start date: January 21, 2019
Phase: Early Phase 1
Study type: Interventional

The current study aims to assess the use of pilocarpine and brimonidine to improve near visual acuity in patietns with monofocal intraocular lenses. Thirty-three subjects with be enrolled and baseline visual acuity with be measured at near and distance. This will be compared to visual acuity after drop administration over 6 hours. A quality of life questionnaire will also be evaluated.

NCT ID: NCT03823092 Recruiting - Cataract Clinical Trials

Polarization Perception in Health and Disease. Testing a New Sight Test

TaNSiT
Start date: November 9, 2017
Phase:
Study type: Observational

A study to assess the utility of human polarization pattern perception for the detection, diagnosis and monitoring of eye disease

NCT ID: NCT03751241 Recruiting - Pseudophakia Clinical Trials

Reading Quality in Three Different Patient Groups

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Influence of different ophthalmic conditions after cataract surgery (extended range of vision IOL (EROV) with micromonovision, minimonovision with standard IOL and single focus distance vision with standard IOL) on reading quality.

NCT ID: NCT02668523 Recruiting - Presbyopia Clinical Trials

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects

Start date: December 2015
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of the Raindrop Near Vision Inlay implanted in bilateral pseudophakes with presbyopia for improvement of near and intermediate vision.